Neuronetics: Reality Set In [Seeking Alpha]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Neuronetics' losses remain relatively large, and the company's balance sheet provides it with limited flexibility. The stock may have further to fall if Neuronetics is not able to demonstrate a clear path to profitability in the coming quarters. Neuronetics' ( NASDAQ: STIM ) share price collapsed after the company reported slightly soft Q1 2024 results. There wasn't really anything in the earnings which warranted a large selloff, but as I previously suggested , the increase in Neuronetics' share price in recent months wasn't justified by fundamentals either. On a positive note, Neuronetics is seeing strong treatment demand, but there is a growing question about the company's ability to place systems. The charitable interpretation of this is that Neuronetics is limiting systems growth so that it can provide sufficient support in the field. Competition is a concern though, and slow growth in the installed base will eventually lead to weak treatment revenue growth. More importan
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsGlobeNewswire
- Neuronetics, Inc. (NASDAQ: STIM) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.MarketBeat
- Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Neuronetics Reports Record First Quarter 2024 Financial and Operating Results [Yahoo! Finance]Yahoo! Finance
STIM
Earnings
- 5/7/24 - Beat
STIM
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 5/7/24 - Form 8-K
- STIM's page on the SEC website